Plus Therapeutics, Inc. (PSTV)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research

Current Price

as of Feb 14, 2025

$1.24

P/E Ratio

N/A

Market Cap

$7.31M

Description
Add to research

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.

Metrics
Add to research

Overview

  • HQAustin, TX
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerPSTV
  • Price$1.24+3.33%

Trading Information

  • Market cap$7.31M
  • Float97.45%
  • Average Daily Volume (1m)22,368
  • Average Daily Volume (3m)47,936
  • EPS-$2.42

Company

  • Revenue$5.73M
  • Rev growth (1yr)17.42%
  • Net income-$2.87M
  • Gross margin84.07%
  • EBITDA margin-244.99%
  • EBITDA-$3.57M
  • EV$10.08M
  • EV/Revenue1.76
  • P/EN/A
  • P/S1.70
  • P/BN/A
  • Debt/EquityN/A
Documents
Add to research